TCTR20170509001招募中2 期
A study of effects on cognitive function and neuropsychiatric symptoms in patients with mild to moderate Alzheimer's disease
Department for Development of Thai Traditional and Alternative Medicine, Ministry of Public Health0 个研究点目标入组 180 人开始时间: 2017年5月9日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50 Years 至 100 Years（—）
- 性别
- All
入选标准
- •1) Age >50 years with the following diagnostic criteria for AD
- •- Diagnostic and Statistical Manual of Mental Disorders-IV Text Revision (DSM-IV-TR)
- •- National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorder Associations Criteria (NINCDS-ADRDA) for probable AD
- •- TMSE score 12-25
- •- Modified Hachinski Ischemic Score < 4
- •2. voluntarily participate in the project with the approval of their legal representative
- •3.received the neuroimaging before the recruitment within one year with compatible findings
- •4.if the subjects received acetylcholinesterase inhibitor (donepezil, rivastigmine, galantamine) or NMDA receptor inhibitor (memantine), the dose had to be stable within four months, and there was no plan to adjust the quantity during the study period
- •5. before the subjects suffered AD, they had to be literate and able to communicate with other people
- •6.There had to be reliable caregivers who provided care at least five days per week and at least 3 hours per day. The caregivers had to know the subjects' symptoms regarding ADLS, cognition, and BPSD. The caregivers had to be able to bring the subjects to the study center.
排除标准
- •1.By clinical and neuroimaging data, there must be no other brain abnormality apart from AD
- •2.Unstable medical illness, which the researchers consider to affect the study protocol or the assessment of the mangosteen side effect.
- •a)Disability which could result in the incomplete study follow up such as blindness, deafness, communication problems not from AD
- •b)History of cancer within five years, which is considered to be a high chance of recurrence
- •c)Systolic blood pressure <90 mmHg or >180 mmHg, or heart rate < 50/min
- •d) Malignant arrhythmia
- •e) Unstable cardiac conditions such as unstable angina, decompensated heart failure, arrhythmia
- •f)History of head injury or stroke with residual neurological deficit
- •g)Epilepsy patient who is still on antiepileptic drugs
- •3.other brain diseases result in dementia, such as Parkinson disease dementia, frontotemporal dementia, vascular dementia, Lewy bodies dementia and NPH
- •4.The subjects are currently afflicted with a psychiatric disease which could interfere with the evaluation of the study result. If the neuropsychiatric problems are from dementia, the subjects can be recruited.
- •5.Known case of human immunodeficiency virus (HIV) infection. If the HIV status is unknown, the HIV test is not necessary.
- •6.No reliable informant
- •7.Screening laboratory results are abnormal in the following criteria
- •- Absolute Neutrophils Count (ANC) < 2x109 /L
- •- Platelet <100 x109 /L
- •- AST/ALT>2.5 x upper limit
- •- Bilirubin >1.5x upper limit
- •- Blood urea nitrogen >1.5x upper limit or creatinine clearance <30 mL/min (CKD-Epi formula)
- •8.Use of the following drugs within 30 days before recruitment
- •a)narcotics use more than two times/week
- •b)Low potency antipsychotics (e.g., chlorpromazine, thioridazine)
- •c)Drugs with high anticholinergic activity such as tricyclic antidepressants
- •d)Antiparkinson drugs (eg selegiline, levodopa, amantadine)
- •e)Short-acting insulin
- •g)Clozapine
- •h)Bupropion
- •If the subjects have used sedatives/anxiolytics or atypical/high potency antipsychotic drugs before recruitment, the dose must not be adjusted within 30 days before the study entry.
研究者
相似试验
招募中
不适用
Evaluation of effects on cognitive function and swallowing activity following after continuous chewing training with chewing start food of process lead in cerebrovascular disease: an open-label, randomized controlled.Cerebral vascular diseaseJPRN-UMIN000029603Medical corporation Sonodakai Takenotsuka Noushinkei Rehabilitation Hospital20
已完成
Unknown
Study of the effect on cognitive function by continuous intake of polyamineHealthy AdultsJPRN-UMIN000049672Healthcare Systems Co., Ltd.54
已完成
不适用
The effect of the cognitive function and cerebral white matter lesions of pitavastatin in hypercholesterolemic patients with cognitive dysfunction.Hypercholesterolemic patients with cognitive dysfunctionJPRN-UMIN000013231Department of Geriatric Medicine, Kyorin University School of Medicine60
已完成
不适用
Effect on cognitive function.Healthy subjectsJPRN-UMIN000031366CPCC Company Limited14
已完成
不适用
Study of evaluation of neurocognitive function and psycho-social problem in HIV-infected hemophiliaHemophilia, HIV infection, neurocognitive disorderJPRN-UMIN000033632HIV infection Medical Support Center, Hokkaido University Hospital15